dioxadrol 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 3158 | 6495-46-1 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
See also records for d- and l-forms which are referred to as dexoxadrol and levoxadrol, respectfully
|
Drug dosage:
None
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D000700 | Analgesics |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D018689 | Sensory System Agents |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.08 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Sigma non-opioid intracellular receptor 1 | Membrane other | Ki | 7.46 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| C0114219 | UMLSCUI |
| CHEMBL1165411 | ChEMBL_ID |
| CHEMBL26479 | ChEMBL_ID |
| C005840 | MESH_SUPPLEMENTAL_RECORD_UI |
| 66270 | PUBCHEM_CID |
| 1505 | INN_ID |
| 4D70V7R51N | UNII |
Pharmaceutical products:
None